MESD and adenoma: To determine whether measurement of SDC2 methylation in stool DNA was capable of detecting CRC and adenoma, meSDC2 LTE-qMSP was performed using stool DNA from 50 CRC patients at various stages and 21 patients with small size (< 1.0 cm) of adenoma.